Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eton Pharmaceuticals (ETON) Capital Expenditures (2019 - 2025)

Historic Capital Expenditures for Eton Pharmaceuticals (ETON) over the last 6 years, with Q3 2025 value amounting to $284000.0.

  • Eton Pharmaceuticals' Capital Expenditures changed N/A to $284000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $296000.0, marking a year-over-year increase of 201428.57%. This contributed to the annual value of $26000.0 for FY2024, which is N/A changed from last year.
  • Latest data reveals that Eton Pharmaceuticals reported Capital Expenditures of $284000.0 as of Q3 2025.
  • In the past 5 years, Eton Pharmaceuticals' Capital Expenditures ranged from a high of $284000.0 in Q3 2025 and a low of $2000.0 during Q3 2021
  • Over the past 4 years, Eton Pharmaceuticals' median Capital Expenditures value was $12000.0 (recorded in 2022), while the average stood at $44250.0.
  • Per our database at Business Quant, Eton Pharmaceuticals' Capital Expenditures tumbled by 9090.91% in 2021 and then soared by 20000.0% in 2022.
  • Over the past 4 years, Eton Pharmaceuticals' Capital Expenditures (Quarter) stood at $4000.0 in 2021, then surged by 200.0% to $12000.0 in 2022, then changed by 0.0% to $12000.0 in 2024, then surged by 2266.67% to $284000.0 in 2025.
  • Its Capital Expenditures was $284000.0 in Q3 2025, compared to $12000.0 in Q4 2024 and $14000.0 in Q1 2024.